ERBB2&ERBB3 Dimerization CHO
CBP74452
詢 價(jià)
索取Protocol
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. Background | |
| N/A | |
| II. Description | |
| N/A | |
| II. Introduction | |
| Expressed gene: | HER2&HER3 |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10% FBS+5 μg/ml Puromycin+5 μg/ml Blasticidin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
 Figure 1. Recombinant ERBB2&ERBB3 Dimerization CHO stably expressing ERBB2&ERBB3.  Figure 2. Dose Response of Ligands in ERBB2&ERRB3 Dimerization CHO( C14).  Figure 3. Inhibition of Human NRG1-β1 induced ERBB2&ERBB3 Dimerization by ERBB3 or ERBB3 Abs in ERBB2&ERBB3 Dimerization CHO( C14).  Figure 4. Inhibition of Human NRG1-β2 induced ERBB2&ERBB3 Dimerization by ERBB3 or ERBB3 Abs in ERBB2&ERBB3 Dimerization CHO(C14). |
|
